Acid-Labile Polyvinylamine Micro- and Nanogel Capsules.
Hollow nanoparticles represent an emerging area of development for the encapsulation of active ingredients. Expanding the capabilities of these nanomaterials will require continued efforts to infill properties such as size control, biodegradability, and environmental responsiveness. Acid-labile poly(N-vinylformamide) (PNVF) nanocapsules were synthesized by free radical polymerization of N-vinylformamide on the surface of silica nanoparticles. Polymerization in the presence of a novel crosslinker that contains an acid-labile ketal facilitated stable etching of silica nanoparticle templates using sodium hydroxide and recovery of degradable PNVF nanocapsules. The formamido side group of PNVF was then hydrolyzed by extended exposure to sodium hydroxide to produce polyvinylamine (PVAm) micro- and nanocapsules. Both capsule types demonstrated an increasing dissolution rate as pH decreased. In addition, PVAm nanocapsules exhibited swelling in proportion to the relative charge density of the PVAm network (a function of the degree of formamide hydrolysis and pH), presumably due to the repulsion of positively charged amino groups within the elastic shell network. The synthetic approaches reported provide methods to endow nanocapsules with key attributes such as size control, pH sensitive degradation, swelling in response to pH, and amine functionality.
Shi
Lianjun
L
Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, KS 66047.
Berkland
Cory
C
J Am Chem Soc. 2001 Jun 13;123(23):5431-6
11389623
Mol Cell Proteomics. 2004 Aug;3(8):746-69
15143156
J Am Chem Soc. 2006 May 10;128(18):5988-9
16669639
Science. 1999 May 14;284(5417):1143-6
10325219
Clin Biochem. 2000 Jul;33(5):345-50
11018685
Angew Chem Int Ed Engl. 1998 Sep 4;37(16):2201-2205
29711461
Mol Pharm. 2005 Jan-Feb;2(1):83-91
15804181
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):4995-5000
12704236
J Colloid Interface Sci. 2003 Oct 15;266(2):282-94
14527451
Biotechnol Bioeng. 2001 Apr 20;73(2):135-45
11255161
Bioconjug Chem. 1999 Nov-Dec;10(6):993-1004
10563768
Pharm Res. 2006 Sep;23(9):2190-9
16952009
Biomacromolecules. 2005 Nov-Dec;6(6):3433-9
16283776
J Control Release. 1998 Mar 2;52(1-2):119-29
9685942
J Am Chem Soc. 2005 Oct 5;127(39):13448-9
16190679
Biomacromolecules. 2005 Nov-Dec;6(6):3005-9
16283720
Pathophysiol Haemost Thromb. 2006;35(1-2):37-45
16855345
Chemistry. 2006 Jul 24;12(22):5770-8
16710868
J Colloid Interface Sci. 1998 Jan 15;197(2):293-308
9466871
J Am Chem Soc. 2004 Jun 30;126(25):7940-5
15212543
Bioconjug Chem. 2003 Sep-Oct;14(5):934-40
13129396
J Control Release. 2003 Jul 31;90(3):323-34
12880699
Mol Pharm. 2006 May-Jun;3(3):340-50
16749866